European Unified Registries for Heart Care Evaluation and Randomised Trials Italy
ConditionACS - Acute Coronary Syndrome
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHeart Care Foundation
About this trial
Major advances in cardiovascular medicine have been driven by innovations in basic research in biological and technical sciences. Despite the clear evidence regarding the treatments that have been demonstrated to be useful to improve patients' outcomes, their transferability to everyday clinical practice seems to be at least suboptimal. The European Society of Cardiology (ESC), therefore, planned to support a program, denominated EuroHeart, for continuous data collection of standardized and/or harmonized variables in common cardiovascular diseases, such as ACS, HF and A Fib. EuroHeart is an observational, prospective, multicentre initiative with continuous data collection in consecutive patients with ACS, HF and A Fib to support continuous quality of care improvement through the evaluation of quality indicators (QIs) defined by the ESC. All patients included in the EuroHeart initiative, will enter a 12 month longitudinal follow-up with the collection of clinical events and clinical status data.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients ≥18 years of age.
Males and females at birth.
Hospitalization for Acute Coronary Syndrome (ACS)
Heart failure (HF, outpatients, and/or inpatients)
Disqualifiers
patients who do not sign the consent to participate in the project and/or Privacy
Trial population
patients with ACS
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Adherence to European Society of Cardiology (ESC) quality indicators
Other interventionEuroHeart is an initiative of the European Society of Cardiology (ESC) supporting continuous quality-of-care improvement through individual patient data collection. The present registry component refers specifically to the Italian implementation of the EuroHeart programme, aimed at monitoring and improving adherence to ESC quality indicators within Italian clinical practice.
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Adherence to ESC Quality indicators (STEMI patients reperfused)
Proportion of patients with STEMI reperfused among those eligible (onset of symptoms to diagnosis \<12 hours)
Time frame
From enrollment to 12 months follow-up2
Adherence to ESC Quality indicators (STEMI patients reperfused <90 min)
Proportion of patients with STEMI who receive timely reperfusion with PCI (wire crossing) within 90 minutes from initial diagnostic ECG
Time frame
From enrollment to 12 months follow-up3
Adherence to ESC Quality indicators (coronary angiography in NSTEMI patients within 24 hours)
Rate of NSTEMI patients who receive invasive within 24 hours from their diagnosis
Time frame
From enrollment to 12 months follow-up4
Adherence to ESC Quality indicators (radial access)
Use of radial access in case of invasive strategy for patients with STEMI and NSTEMI
Time frame
From enrollment to 12 months follow-upSecondary outcomes
1
Cardiovascular and non-cardiovascular events during follow-up
Proportion of patients with clinical events at 12 months
Time frame
12 months follow-upSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov